石药集团此前预告过的大BD(商务拓展或商务开发)正式落地。该项与跨国药企阿斯利康的战略合作是聚焦AI驱动的药物研发项目,涉及金额超53亿美元(约为380亿元人民币),远超石药集团2024年290亿元的营收规模。6月13日,石药集团股价以8.84港元/股报收,最新市值为1018亿港元。超53亿美元石药集团6月13日晚公告称,公司已与全球生物制药领导者阿斯利康订立战略研发合作协议,以利用集团的AI引擎...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.